LASTET 20mg|ml Injection 5mlx10s

 846.00

Manufactured by:
Active Pharmaceutical Ingredient:
Drug Strength: 20mg/ml
Drug Form : Injection
Pack Size : 5mlx10s

Etoposide:20mg/ml | Cytotoxic (anti-neoplastic) drugs

Alternate brands of LASTET 20mg|ml Injection 5mlx10s

Brand Name Price Savings
VEPESID 20mg|ml Injection 10s  6,603.52 You will pay -5757.52 more
ONCOSIDE 20mg|ml Injection 5ml Vial  669.50 You can save 176.5
ETOPOSID 20mg|ml Injection 1x5ml  550.00 You can save 296
ETOPUL 20mg|ml Injection 5 ampule  626.50 You can save 219.5
ETOCID 20mg|ml Injection Vial  550.00 You can save 296
List of alternate brands

Manufactured / Marketed By : S.Ejazuddin Product Form : InjectionPack Size : 5mlx10sIngredients : Etoposide:20mg/mlGeneric Category : Cytotoxic (anti-neoplastic) drugs

Reviews

There are no reviews yet.

Be the first to review “LASTET 20mg|ml Injection 5mlx10s”

How it works

LASTET 20mg|ml Injection 5mlx10s works by slowing or stopping the growth of cancer cells in your body.

Side effects

Major & minor side effects for LASTET 20mg|ml Injection 5mlx10s

  • Nausea and Vomiting
  • Hair loss severe
  • Loss of appetite severe
  • Decrease in blood cell count severe
  • Anemia severe
  • Low blood pressure
  • Abnormal Liver function severe
  • Heart attack severe
  • Infections severe
  • Rash

Uses of LASTET 20mg|ml Injection 5mlx10s

What is it prescribed for?

  • Small Cell Lung Cancer

    LASTET 20mg|ml Injection 5mlx10s is used in the treatment of small cell lung cancer, a highly malignant and aggressive cancer affecting the lungs.

  • Testicular Cancer

    LASTET 20mg|ml Injection 5mlx10s is used in the treatment of cancer that affects the testes.

  • Acute Myeloid Leukemia

    LASTET 20mg|ml Injection 5mlx10s is used in the treatment of acute myeloid leukemia, a type of cancer that affects certain blood cells.

  • Hodgkin's Lymphoma

    LASTET 20mg|ml Injection 5mlx10s is used in the treatment of Hodgkin's Lymphoma, a type of cancer that affects a certain type of white blood cells called lymphocytes.

  • Ovarian Cancer

    This medicine is used in the treatment of cancer that affects the ovaries.

  • Non-Hodgkin's Lymphoma

    This medicine is used in the treatment of non-Hodgkin's lymphoma, a type of cancer that affects certain cells of the lymphatic system.

Concerns

Frequently asked questions

  • Onset of action

    The amount of time required for this medicine to show its action is not clinically established.

  • Duration of Effect

    The amount of time for which this medicine remains active in the body is not clinically established.

  • Safe with Alchohol?

    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

  • Is it habit forming?

    No habit forming tendencies were reported.

  • Usage in pregnancy?

    This medicine is not recommended for use in pregnant women except in life-threatening conditions. All the risks and benefits should be discussed with the doctor before receiving this medicine.

  • Usage while breast-feeding?

    This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before receiving this medicine. Your doctor may advise you to discontinue breastfeeding for a specific period of time or prescribe an alternative medicine based on your clinical condition.

When not to use?

  • Allergy

    This medicine is not recommended for use in patients with a known allergy to LASTET 20mg|ml Injection 5mlx10s or any other inactive ingredients present along with this medicine.

  • Severe myelosuppression

    This medicine is not recommended for use in patients with a severe bone marrow suppression (WBC less than 2,000 cells/mm3 or platelet count less than 75,000 cells/mm3) not due to malignant disease since it may worsen the patient's condition.

  • Live vaccines

    Administration of live vaccines is contraindicated during treatment with this medicine due to the increased risk of serious adverse effects including life-threatening infections and death.

Warnings

Warnings for special population
  • Pregnancy

    This medicine is not recommended for use in pregnant women except in life-threatening conditions. All the risks and benefits should be discussed with the doctor before receiving this medicine.

  • Breast-feeding

    This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before receiving this medicine. Your doctor may advise you to discontinue breastfeeding for a specific period of time or prescribe an alternative medicine based on your clinical condition.

General Warnings
  • Myelosuppressuion

    This medicine may cause significant bone marrow suppression in some patients. This increases the risk of life-threatening infections and other associated complications. Close monitoring of blood cell counts is recommended during treatment with this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

  • Anaphylactic reactions

    This medicine may cause severe hypersensitivity or anaphylactic reactions in some patients. The symptoms of such reactions may include chills, fever, increased heart rate, breathing difficulties, low blood pressure, etc. Close monitoring of the patient for any such reactions is recommended during treatment with this medicine. Appropriate corrective measures, dose adjustments, or replacement with a suitable alternative may be required in some cases based on the clinical condition.

  • Pediatric Use

    This medicine should be used with extreme caution in patients below 18 years of age since there is limited information on the use of this medicine in such patients.

  • Rapid intravenous injection

    LASTET 20mg|ml Injection 5mlx10s is intended for slow intravenous infusion only. It must not be given by rapid intravenous injection. Rapid intravenous injections of this medicine may cause serious abnormalities in heart rate and other cardiac toxicities.

  • Drowsiness

    This medicine may rarely cause drowsiness in some patients. It is advised that you do not perform any activities that require high mental alertness such as driving a vehicle or operating heavy machinery if you experience drowsiness during treatment with this medicine.

Dosage

  • Missed Dose

    If you miss a dose, contact your doctor or pharmacist immediately to establish a new dosing schedule. Do not double the dose to make up for the missed one.

  • Overdose

    The injection form of this medicine is usually administered in the clinic/hospital setting. Hence, the likelihood of an overdose is very low. However, emergency medical treatment will be initiated if an overdose is suspected. If you suspect an overdose with the oral form of this medicine, contact your doctor immediately for further instructions or visit the nearest emergency room.

Interactions

Interaction with Medicines
  • Phenobarbital moderate
  • Live attenuated vaccines and related products severe
  • Adalimumab severe
  • Phenytoin moderate
  • Carboplatin moderate
  • Clozapine severe
Disease interactions
  • severe

    This medicine is not recommended for use in patients with active infections since it may worsen the patient's condition. Replacement with a suitable alternative should be considered under your doctor's supervision.

  • severe

    This medicine should be used with extreme caution in patients with known myelosuppression since it may worsen the patient's condition. Close monitoring of blood cell counts is recommended during treatment with this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

General Instructions

Carefully follow all instructions given by your doctor and report any severe undesirable side effects to the doctor immediately. Do not consume the oral form of this medicine in larger or smaller quantities than recommended. Ensure that the treatment course is completed. Do not stop the use of this medicine without consulting your doctor.

Other details

  • To be taken on an empty stomach
  • To be taken as instructed by doctor
  • May cause sleepiness

References

Additional Information>

One of the following licensed pharmacy from the nearest location will deliver LASTET 20mg|ml Injection 5mlx10s. The details of the licensed pharmacy shall be shared once you request the drugs and the respective pharmacy accepts your request based on valid prescription and availability.

Questions and Answers

There are no questions yet. Be the first to ask a question about this product.

Only registered users are eligible to enter questions

Shopping Cart

Medicalstore.com.pk © All rights reserved

Made with ❤ by Dairah